Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. uri icon

Overview

abstract

  • This portion of the NCCN Guidelines for Hodgkin lymphoma (HL) focuses on the management of classical HL. Current management of classical HL involves initial treatment with chemotherapy or combined modality therapy followed by restaging with PET/CT to assess treatment response using the Deauville criteria (5-point scale). The introduction of less toxic and more effective regimens has significantly advanced HL cure rates. However, long-term follow-up after completion of treatment is essential to determine potential long-term effects.

authors

publication date

  • May 1, 2017

Research

keywords

  • Hodgkin Disease

Identity

Scopus Document Identifier

  • 85019066211

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2017.0064

PubMed ID

  • 28476741

Additional Document Info

volume

  • 15

issue

  • 5